Back to Search
Start Over
CDC'S ACIP recommends Merck's Capvaxive for pneumococcal vaccination in adults 50 years of age and older
- Source :
- PharmaBiz. October 25, 2024
- Publication Year :
- 2024
-
Abstract
- Byline: Rahway Merck, known as MSD outside of the United States and Canada, announced that the US Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813611316